According to Smith & Nephew
's latest financial reports the company has $0.30 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.30 B | -13.71% |
2022-12-31 | $0.35 B | -72.87% |
2021-12-31 | $1.29 B | -26.79% |
2020-12-31 | $1.76 B | 536.1% |
2019-12-31 | $0.27 B | -24.11% |
2018-12-31 | $0.36 B | 115.98% |
2017-12-31 | $0.16 B | 69% |
2016-12-31 | $0.10 B | -16.67% |
2015-12-31 | $0.12 B | 29.03% |
2014-12-31 | $93 M | -32.12% |
2013-12-31 | $0.13 B | -23.03% |
2012-12-31 | $0.17 B | -3.26% |
2011-12-31 | $0.18 B | -11.11% |
2010-12-31 | $0.20 B | 7.81% |
2009-12-31 | $0.19 B | 32.41% |
2008-12-31 | $0.14 B | -14.71% |
2007-12-31 | $0.17 B | -50.87% |
2006-12-31 | $0.34 B | 129.14% |
2005-12-31 | $0.15 B | 357.58% |
2004-12-31 | $33 M | 26.92% |
2003-12-31 | $26 M | -28.29% |
2002-12-31 | $36.25 M | -17% |
2001-12-31 | $43.68 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $22.92 B | 7,491.72% | ๐บ๐ธ USA |
Boston Scientific BSX | $0.86 B | 186.42% | ๐บ๐ธ USA |
Edwards Lifesciences EW | $1.64 B | 444.54% | ๐บ๐ธ USA |
Stryker Corporation SYK | $3.05 B | 910.93% | ๐บ๐ธ USA |
Orthofix Medical
OFIX | $33.1 M | -89.04% | ๐บ๐ธ USA |
CONMED CNMD | $24.29 M | -91.95% | ๐บ๐ธ USA |